| Guillermina Nava, MD | |
|
4160 John R St, Suite 615, Detroit, MI 48201-2020 | |
| (313) 745-4195 | |
| (313) 993-8669 |
| Full Name | Guillermina Nava |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 23 Years |
| Location | 4160 John R St, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164631024 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 35-089408 (Ohio) | Secondary |
| 208200000X | Plastic Surgery | 4301093488 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Harper University Hospital | Detroit, MI | Hospital |
| Karmanos Cancer Center | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physician Group | 8628087681 | 345 |
News Archive
A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease.
Hepatocytes - the chief functional cells of the liver - are natural regenerators, and the lymph nodes serve as a nurturing place where they can multiply.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.
› Verified 2 days ago
| Entity Name | University Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447299797 PECOS PAC ID: 8628087681 Enrollment ID: O20060419000518 |
News Archive
A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease.
Hepatocytes - the chief functional cells of the liver - are natural regenerators, and the lymph nodes serve as a nurturing place where they can multiply.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Guillermina Nava, MD 1560 E Maple Rd, Suite 400 - Credentialing, Troy, MI 48083-1189 Ph: (248) 581-5974 | Guillermina Nava, MD 4160 John R St, Suite 615, Detroit, MI 48201-2020 Ph: (313) 745-4195 |
News Archive
A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes in patients with primary myelofibrosis who are 70 years or younger and candidates for stem cell transplant to treat their disease.
Hepatocytes - the chief functional cells of the liver - are natural regenerators, and the lymph nodes serve as a nurturing place where they can multiply.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.
› Verified 2 days ago
Aamir Siddiqui, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Jamie Marie Dilauro Hall, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Kenneth J. Moquin, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-2436 | |
Donald M. Ditmars, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: Henry Ford Health System, 2799 West Grand Blvd., Detroit, MI 48202 Phone: 313-916-7425 Fax: 313-874-3623 | |
Dr. Faisal M Almufarrej, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Beaubien St, Detroit, MI 48201 Phone: 313-745-0247 Fax: 313-993-8783 | |
Donna G. Tepper, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 2799 West Grand Boulevard, Detroit, MI 48202 Phone: 313-916-9106 Fax: 313-916-1249 |